$88.15 Million in Sales Expected for MCBC Holdings Inc (MCFT) This Quarter

Brokerages predict that MCBC Holdings Inc (NASDAQ:MCFT) will post $88.15 million in sales for the current quarter, Zacks reports. Five analysts have issued estimates for MCBC’s earnings. The lowest sales estimate is $85.76 million and the highest is $88.91 million. MCBC reported sales of $58.49 million in the same quarter last year, which indicates a positive year over year growth rate of 50.7%. The company is scheduled to report its next quarterly earnings report on Thursday, May 10th.

According to Zacks, analysts expect that MCBC will report full-year sales of $88.15 million for the current financial year, with estimates ranging from $307.98 million to $318.82 million. For the next financial year, analysts forecast that the firm will report sales of $360.18 million per share, with estimates ranging from $342.62 million to $369.13 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for MCBC.

How to Become a New Pot Stock Millionaire

MCBC (NASDAQ:MCFT) last issued its earnings results on Thursday, February 8th. The company reported $0.42 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.09. The firm had revenue of $78.40 million during the quarter, compared to analysts’ expectations of $74.65 million. MCBC had a net margin of 9.07% and a return on equity of 149.34%. The firm’s revenue for the quarter was up 53.4% compared to the same quarter last year. During the same period last year, the firm posted $0.26 earnings per share.

A number of analysts recently weighed in on the stock. BidaskClub cut shares of MCBC from a “buy” rating to a “hold” rating in a report on Thursday, December 14th. Robert W. Baird raised their target price on shares of MCBC from $24.00 to $29.00 and gave the stock an “outperform” rating in a report on Friday, February 9th. Zacks Investment Research upgraded shares of MCBC from a “hold” rating to a “buy” rating and set a $28.00 target price for the company in a report on Wednesday, February 14th. ValuEngine cut shares of MCBC from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, B. Riley raised their target price on shares of MCBC from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, December 18th. Six analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. MCBC has an average rating of “Buy” and a consensus target price of $28.06.

A number of institutional investors have recently bought and sold shares of the stock. BlackRock Inc. boosted its stake in MCBC by 54.7% in the 4th quarter. BlackRock Inc. now owns 2,387,378 shares of the company’s stock worth $53,046,000 after purchasing an additional 843,953 shares during the period. Renaissance Technologies LLC boosted its stake in MCBC by 34.6% in the 4th quarter. Renaissance Technologies LLC now owns 1,209,000 shares of the company’s stock worth $26,864,000 after purchasing an additional 310,900 shares during the period. Divisar Capital Management LLC boosted its stake in MCBC by 1.7% in the 4th quarter. Divisar Capital Management LLC now owns 938,989 shares of the company’s stock worth $20,864,000 after purchasing an additional 15,779 shares during the period. Royce & Associates LP boosted its stake in MCBC by 18.8% in the 4th quarter. Royce & Associates LP now owns 753,689 shares of the company’s stock worth $16,747,000 after purchasing an additional 119,332 shares during the period. Finally, Wells Fargo & Company MN boosted its stake in MCBC by 7.0% in the 3rd quarter. Wells Fargo & Company MN now owns 529,091 shares of the company’s stock worth $10,783,000 after purchasing an additional 34,401 shares during the period. 95.38% of the stock is owned by hedge funds and other institutional investors.

Shares of MCBC stock opened at $25.82 on Friday. The firm has a market cap of $486.59, a P/E ratio of 20.33, a P/E/G ratio of 0.97 and a beta of 1.17. MCBC has a 1-year low of $15.30 and a 1-year high of $28.62. The company has a current ratio of 0.62, a quick ratio of 0.23 and a debt-to-equity ratio of 3.29.

COPYRIGHT VIOLATION NOTICE: “$88.15 Million in Sales Expected for MCBC Holdings Inc (MCFT) This Quarter” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3297717/88-15-million-in-sales-expected-for-mcbc-holdings-inc-mcft-this-quarter.html.

MCBC Company Profile

MCBC Holdings, Inc (MCBC) is a holding company. The Company is a designer and manufacturer of inboard tournament ski boats and V-drive runabouts under the MasterCraft brand. The Company operates through two segments: MasterCraft and Hydra-Sports. The MasterCraft product brand consists of recreational performance boats primarily used for water skiing, wakeboarding and wake surfing, and general recreational boating.

Get a free copy of the Zacks research report on MCBC (MCFT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MCBC (NASDAQ:MCFT)

Receive News & Ratings for MCBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MCBC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nitto Denko  Lowered to “Hold” at Zacks Investment Research
Nitto Denko Lowered to “Hold” at Zacks Investment Research
Navigant Consulting  Set to Announce Quarterly Earnings on Tuesday
Navigant Consulting Set to Announce Quarterly Earnings on Tuesday
Newfield Exploration  Set to Announce Earnings on Tuesday
Newfield Exploration Set to Announce Earnings on Tuesday
Homology Medicines  Now Covered by Bank of America
Homology Medicines Now Covered by Bank of America
$0.12 Earnings Per Share Expected for Finisar  This Quarter
$0.12 Earnings Per Share Expected for Finisar This Quarter
Kansas City Southern Railway  Given New $132.00 Price Target at Credit Suisse Group
Kansas City Southern Railway Given New $132.00 Price Target at Credit Suisse Group


© 2006-2018 Ticker Report. Google+.